The use of eGFR and ACR to predict decline in renal function in people with diabetes
about
Factors Associated with the Decline of Kidney Function Differ among eGFR Strata in Subjects with Type 2 Diabetes Mellitus.Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study.Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic NephropathyThe eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multietEffects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.Spectrum of renal disease in diabetes.Updating the natural history of diabetic nephropathy.Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease.Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared to other causes of chronic kidney disease.Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus.The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohort.Identification of a multistate continuous-time nonhomogeneous Markov chain model for patients with decreased renal function.New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function.
P2860
Q36506625-6216334B-DB33-4ACA-BC0B-2C91B309BCA9Q36844972-9558C6E2-77FE-441F-AD94-D1CB6EC5C4B6Q37162922-124E1BB5-30B5-46F4-B1FA-5AF5113AD0A1Q37502281-0B95F414-FA82-4D9F-A2A5-B6834EE709C9Q37696496-B28E2EE5-D371-40DA-BC16-36C9C3B269FBQ38217772-89AA9A64-214D-4D76-80F4-90230B47EE4BQ38258271-39F87145-2AD3-46EC-9F9D-FC04B3396C0DQ38628139-72A76A90-D848-4C1F-A7DE-C58D322C1DA7Q40901996-D22E371F-775E-406B-9DDD-9B2A8D6C7E91Q40955437-3FB7E6A7-95A3-49D6-BF02-C62B218CE6B2Q47953908-46239EF5-FFAC-4848-8618-B00A0A1754D3Q50461493-E0692D12-2BD3-48F6-BBD3-F59B6C70B02AQ51282642-126C9FB4-D316-4A25-BDD1-B06809B043E7Q53124728-265EBF37-4FD6-4A48-9D9D-1AC1C597BFFF
P2860
The use of eGFR and ACR to predict decline in renal function in people with diabetes
description
im September 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 13 September 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2010
@uk
name
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@en
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@nl
type
label
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@en
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@nl
prefLabel
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@en
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@nl
P2093
P50
P356
P1476
The use of eGFR and ACR to predict decline in renal function in people with diabetes
@en
P2093
Donal J O'Donoghue
Patricia G Baker
Philip A Kalra
Rachel J Middleton
Richard A Hoefield
P304
P356
10.1093/NDT/GFQ526
P407
P577
2010-09-13T00:00:00Z